A Green Sign – Lifestyle
Author:
NEURIZON THERAPEUTICS LIMITED
Pfizer’s Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis
March 9, 2026
Korn Ferry Announces Third Quarter Fiscal 2026 Results of Operations
March 9, 2026
Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)
March 9, 2026
DraftKings and ESPN Detail Plans to Provide Account Linking for Customers
March 9, 2026
Neurizon Initiates Dosing of NUZ-001 in HEALEY ALS Platform Trial
March 5, 2026
←
Previous Page
1
…
90
91
92